Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Inpare ApS
APS
Dissolved
Advertising protection
CVR 37138789
Agern Alle 24, 2970
Hørsholm
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2015 · 10 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Inpare ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (2)
SA
Søren Anker Nielsen
Chief Executive Officer
Chief Executive Officer
2023 – 2023
CJ
Claus Juan Møller-San Pedro
Chief Executive Officer
Chief Executive Officer
2023 – 2024
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Holmes Holding ApS
Company
66.67–89.99%
66.67–89.99%
2018
Per Holm
Individual
100%
100%
2023
Afyx Therapeutics A/S
Company
100%
100%
2023
Flovio Labs ApS
Company
33.33–49.99%
33.33–49.99%
2016
Ole Pedersen
Individual
20–24.99%
20–24.99%
2016
Peter David Gruhn
Individual
100%
100%
2015
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Inpare ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network